Li Wenle, Wang Bing, Dong Shengtao, Xu Chan, Song Yang, Qiao Ximin, Xu Xiaofeng, Huang Meijin, Yin Chengliang
Clinical Medical Research Center, Xianyang Central Hospital, Xianyang, China.
Department of Spine Surgery, Second Affifiliated Hospital of Dalian Medical University, Dalian, China.
Front Oncol. 2022 Apr 11;12:851552. doi: 10.3389/fonc.2022.851552. eCollection 2022.
Lymphatic metastasis is an important mechanism of renal cell carcinoma (RCC) dissemination and is an indicator of poor prognosis. Therefore, we aimed to identify predictors of lymphatic metastases (LMs) in RCC patients and to develop a new nomogram to assess the risk of LMs.
This study included patients with RCC from 2010 to 2018 in the Surveillance, Epidemiology, and Final Results (SEER) database into the training cohort and included the RCC patients diagnosed during the same period in the Second Affiliated Hospital of Dalian Medical University into the validation cohort. Univariate and multivariate logistic regression analysis were performed to identify risk factors for LM, constructing a nomogram. The receiver operating characteristic (ROC) curves were generated to assess the nomogram's performance, and the concordance index (C-index), area under curve value (AUC), and calibration plots were used to evaluate the discrimination and calibration of the nomogram. The nomogram's clinical performance was evaluated by decision curve analysis (DCA), probability density function (PDF) and clinical utility curve (CUC). Furthermore, Kaplan-Meier curves were performed in the training and the validation cohort to evaluate the survival risk of the patients with lymphatic metastasis or not. Additionally, on the basis of the constructed nomogram, we obtained a convenient and intuitive network calculator.
A total of 41837 patients were included for analysis, including 41,018 in the training group and 819 in the validation group. Eleven risk factors were considered as predictor variables in the nomogram. The nomogram displayed excellent discrimination power, with AUC both reached 0.916 in the training group (95% confidence interval (CI) 0.913 to 0.918) and the validation group (95% CI 0.895 to 0.934). The calibration curves presented that the nomogram-based prediction had good consistency with practical application. Moreover, Kaplan-Meier curves analysis showed that RCC patients with LMs had worse survival outcomes compared with patients without LMs.
The nomogram and web calculator (https://liwenle0910.shinyapps.io/DynNomapp/) may be a useful tool to quantify the risk of LMs in patients with RCC, which may provide guidance for clinicians, such as identifying high-risk patients, performing surgery, and establishing personalized treatment as soon as possible.
淋巴结转移是肾细胞癌(RCC)播散的重要机制,也是预后不良的指标。因此,我们旨在确定RCC患者淋巴结转移(LMs)的预测因素,并开发一种新的列线图来评估LMs风险。
本研究将2010年至2018年监测、流行病学和最终结果(SEER)数据库中的RCC患者纳入训练队列,并将大连医科大学附属第二医院同期诊断的RCC患者纳入验证队列。进行单因素和多因素逻辑回归分析以确定LMs的危险因素,构建列线图。生成受试者工作特征(ROC)曲线以评估列线图的性能,并使用一致性指数(C指数)、曲线下面积值(AUC)和校准图来评估列线图的辨别力和校准度。通过决策曲线分析(DCA)、概率密度函数(PDF)和临床效用曲线(CUC)评估列线图的临床性能。此外,在训练队列和验证队列中绘制Kaplan-Meier曲线,以评估有或无淋巴结转移患者的生存风险。此外,在构建的列线图基础上,我们获得了一个方便直观的网络计算器。
共纳入41837例患者进行分析,其中训练组41018例,验证组819例。11个危险因素被视为列线图中的预测变量。列线图显示出优异的辨别力,训练组(95%置信区间(CI)0.913至0.918)和验证组(95%CI 0.895至0.934)的AUC均达到0.916。校准曲线表明基于列线图的预测与实际应用具有良好的一致性。此外,Kaplan-Meier曲线分析表明,与无LMs的患者相比,有LMs的RCC患者生存结局更差。